Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Stereotactic electroencephalogram lead placement in patient with hemophilia B: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: November 04, 2025
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results.
Journal: Research and practice in thrombosis and haemostasis
Published: October 02, 2025
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.
Journal: The New England journal of medicine
Published: April 16, 2025
Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 13, 2025
Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trials.
Journal: Blood vessels, thrombosis & hemostasis
Published: December 24, 2024
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
Journal: Research and practice in thrombosis and haemostasis
Published: August 01, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 11, 2024
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 13, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy.
Journal: Blood advances
Published: September 12, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
Journal: The New England journal of medicine
Published: March 16, 2022
Last Updated: 09/26/2026